A detailed history of Sittner & Nelson, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sittner & Nelson, LLC holds 7,388 shares of AMGN stock, worth $2.33 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
7,388
Previous 7,383 0.07%
Holding current value
$2.33 Million
Previous $2.1 Million 9.96%
% of portfolio
1.15%
Previous 1.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $1,313 - $1,596
5 Added 0.07%
7,388 $2.31 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $37,641 - $45,438
-140 Reduced 1.86%
7,383 $2.1 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $5,114 - $5,769
-20 Reduced 0.27%
7,523 $2.17 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $57,723 - $71,665
-264 Reduced 3.38%
7,543 $2.03 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $74,137 - $87,666
-346 Reduced 4.24%
7,807 $1.73 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $49,899 - $60,819
-221 Reduced 2.64%
8,153 $1.97 Million
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $1,145 - $1,455
5 Added 0.06%
8,374 $2.2 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $62,848 - $70,882
280 Added 3.46%
8,369 $1.89 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $93,437 - $103,979
405 Added 5.27%
8,089 $1.97 Million
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $55,913 - $61,855
255 Added 3.43%
7,684 $1.86 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $23,070 - $26,401
116 Added 1.59%
7,429 $1.67 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $121,842 - $142,753
574 Added 8.52%
7,313 $1.56 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $12,613 - $13,993
54 Added 0.81%
6,739 $1.64 Million
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $3,772 - $4,396
17 Added 0.25%
6,685 $1.66 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $1.44 Million - $1.72 Million
6,668 New
6,668 $1.53 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sittner & Nelson, LLC Portfolio

Follow Sittner & Nelson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.